Polaryx Therapeutics Q3 EPS $(0.07) Misses $(0.04) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Misses
Polaryx Therapeutics (NASDAQ:PLYX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.04) by 75 percent. This is a 133.33 percent decrease over losses of $(0.03) per share
Polaryx Therapeutics (NASDAQ:PLYX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.04) by 75 percent. This is a 133.33 percent decrease over losses of $(0.03) per share from the same period last year.